After three years since announcing his initial diagnosis, San Francisco Symphony Music Director Laureate Michael Tilson ...

Conductor Michael Tilson Thomas' brain tumor has returned, and the 80-year-old intends to lead his final performance in April ...

Glioblastoma is the most aggressive and most common malignant brain cancer in adults. It is currently treated with surgery, ...

On his website, conductor and composer Michael Tilson Thomas announced he would “wind down my public appearances” over the next two months.

Lainie Jones has Li-Fraumeni syndrome, which makes her predisposed to having cancer. She's undergoing treatment for ...

HOUSTON, TX / ACCESS Newswire / February 18, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP)("CNS" or the "Company"), a ...

Jade Collett thought she’d “twinged a nerve” — but she had a terminal tumor pressing on the part of the brain that controls ...

Furthermore, they have demonstrated that it is possible to reprogram other cancer cells to become dependent on this enzyme – ...

The market for PDTs in oncology is projected to experience substantial growth in the coming years. This growth is driven by a rising number of patients diagnosed with conditions such as NMSCs, ovarian ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...

Brain Tumor Organoids Accurately Model Patient Response to CAR T Cell Therapy Dec. 9, 2024 — Researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM ...

CNS Pharmaceuticals (CNSP) will present at the 6th Glioblastoma Drug Development Summit being held February 18-20, 2025 in Boston, MA. As part ...